One probing post seems to beget another. Following my recent update on DexCom, I received an email from the man who started that company (!) in 1999, John Burd. He is now CEO of a San Diego startup called Oculir, Inc., developing a futuristic yet hugely exciting new technology for non-invasive glucose testing using infrared (IR) technology to scan your eyes. YOUR EYES!!
The product will be a device about the size of a cell phone that patients simply hold up to their eye, allowing IR radiation technology to test glucose levels. John tells me that there are no potential health risks whatsoever associated with this technology:
"We all give off Mid-IR radiation as heat... We
have done a very small number of human studies with our research
instrumentation and the results are very encouraging. We are now
American Diabetes Association Names New CEO
Non-profit leader Kevin L. Hagan named as new chief exec of national diabetes org after six-month search.
FDA Approves New Basal Insulin
Sanofi's Troujeo has 'flatter profile' of action that helps to avoid lows.
Daytona Win for Racecar Driver with Diabetes!
Type 1 driver Ryan Reed wins first NASCAR series race at Daytona on Feb. 21.
getting ready to run larger human trials and working on the commercial
OK, the company is still in early development stages, but it has recently secured generous funding. Investors say they're backing 2yr-old Oculir because it "has combined the right amount of vision and practical research and technology."
One analyst puts it this way: "The founders of Oculir have combined the best wavelength region for measuring glucose, the Mid-IR, with a unique measurement site, the white of the eye, and protected it with a strong intellectual property position."
John Burd himself is quoted as saying: "People have been working on (non-invasive glucose testing) for decades and we think we've learned from their mistakes and we're coming up with a great product." Keep your eye on Oculir.